Moderna near to find cure for CORONAVIRUS (COVID-19)
Moderna makes it possible to advance the second phase of this month.
If the studies overlap well, a vaccine should be available for wide use by transferring these 12 months or early 2021. Dr. Tal Zaks, modern medical director, said in an interview. The amount of the dose prepared is probably not always regular, but Dr. Zaks said, "We are doing our best to reach as many stacks and hundreds as possible."
In the meantime, there may be no proven treatment or vaccination near the coronavirus. Dozens of companies in the US, Europe and China are competing to deliver vaccines using specific strategies. Some use the same thing as the modern generation, which includes a genetic material phase of the virus known as Messenger Rna or Mrna.
Modern said additional controls on mice vaccinated after inflammation showed that the vaccine should prevent the virus from multiplying in its lungs and that the animals had neutralizing antibody stages, similar to those that did. Got the vaccine.
Three doses of the vaccine have been tried: low, medium and excessive. The first results are based only on low and medium doses. The satisfactory side effects at these doses resulted in redness and pain in the arm of a single patient receiving the injection.
At the best dose, 3 patients had fever, muscle groups and complications. Dr. Zaks in particular said that the symptoms disappeared after an afternoon.
But an overdose is removed from the fate research, not so much because of the collateral consequences, but because of the reality, the lower doses seemed to work so well that an overdose is not always desirable.
"If the dose decreases, we can produce the additional vaccine," said Dr. Expliqua Zaks.
Modern's inventory was 40% for pre-market sales and purchases.
Keywords
Moderna company
Moderna cure
modern warfare
moderna stock
moderna
moderna stock price
modena italy
moderna therapeutics
mederma for scars
If the studies overlap well, a vaccine should be available for wide use by transferring these 12 months or early 2021. Dr. Tal Zaks, modern medical director, said in an interview. The amount of the dose prepared is probably not always regular, but Dr. Zaks said, "We are doing our best to reach as many stacks and hundreds as possible."
In the meantime, there may be no proven treatment or vaccination near the coronavirus. Dozens of companies in the US, Europe and China are competing to deliver vaccines using specific strategies. Some use the same thing as the modern generation, which includes a genetic material phase of the virus known as Messenger Rna or Mrna.
Modern said additional controls on mice vaccinated after inflammation showed that the vaccine should prevent the virus from multiplying in its lungs and that the animals had neutralizing antibody stages, similar to those that did. Got the vaccine.
Three doses of the vaccine have been tried: low, medium and excessive. The first results are based only on low and medium doses. The satisfactory side effects at these doses resulted in redness and pain in the arm of a single patient receiving the injection.
At the best dose, 3 patients had fever, muscle groups and complications. Dr. Zaks in particular said that the symptoms disappeared after an afternoon.
But an overdose is removed from the fate research, not so much because of the collateral consequences, but because of the reality, the lower doses seemed to work so well that an overdose is not always desirable.
"If the dose decreases, we can produce the additional vaccine," said Dr. Expliqua Zaks.
Modern's inventory was 40% for pre-market sales and purchases.
Keywords
Moderna company
Moderna cure
modern warfare
moderna stock
moderna
moderna stock price
modena italy
moderna therapeutics
mederma for scars
No comments